ÌÇÐÄÆƽâ°æ

Research and development expenditure of GSK from 2006 to 2024 (in million British pounds)

© ÌÇÐÄÆƽâ°æ 2026
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2025

Region

Worldwide, United Kingdom

Survey time period

2006 to 2024

Supplementary notes

This statistic was assembled from several editions of the GSK Annual Report.
* Restated.

Citation formats

GSK research and development expenditure 2006-2024

Published by A. Minhas, Mar 13, 2025

GSK (GlaxoSmithKline) plc is a global pharmaceutical and biotech company, headquartered in London. This statistic shows the expenditure on research and development of pharmaceutical company GSK from 2006 to 2024. In 2024, the company invested around *** billion British pounds in research and development.

Log in or register to access precise data.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " GSK (GlaxoSmithKline) "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you GSK (GlaxoSmithKline)

Global positioning

5

Key facts

4

Business segments

3

Competitors

5

Research and development

4

Further Content: You might find this interesting as well

Topics

GSK (GlaxoSmithKline)SanofiAstraZenecaPharmaceutical industry in the UKVaccine-preventable diseases in the U.S.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.